Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems

Cancer Causes & Control(2022)10.1007/s10552-022-01589-4Source: DataRank Database

The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems is a research paper published in Cancer Causes & Control (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.17)OA: greenTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Gretchen L. Gierach ORCID,Mustapha Abubakar ORCID,Lene H. S. Veiga ORCID,Jacqueline B. Vo ORCID,Rochelle E. Curtis ORCID

Live enrichment

PubMed:35583697 PMC:PMC9701354 OpenAlex:https://openalex.org/W4280527278

NCI NIH HHS

Grant: N01 CN067009

NCI NIH HHS

Grant: N01 PC035142

NCI NIH HHS

Grant: R50 CA211115

Intramural NIH HHS

Grant: Z99 CA999999

NCI NIH HHS

Grant: P01 CA154292

Division of Cancer Epidemiology and Genetics, National Cancer Institute

FWCI

0.17

Citation Percentile

0.4%

Citation Trend

2022

2025

greenLicense: https://www.springer.com/tdm

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9701354

publisherhttps://link.springer.com/content/pdf/10.1007/s10552-022-01589-4.pdf

publisherhttps://link.springer.com/article/10.1007/s10552-022-01589-4/fulltext.html

journalhttps://doi.org/10.1007/s10552-022-01589-4

Fields of Study

Breast Cancer Treatment StudiesEstrogen and related hormone effectsMale Breast Health Studies

MeSH Terms

Breast NeoplasmsFemaleHormonesHumansPrognosisReceptors, EstrogenReceptors, ProgesteroneRetrospective StudiesReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesDelivery of Health Care, Integrated

Keywords

MedicineBreast cancerInternal medicineHazard ratioOncologyEstrogen receptorCancerProportional hazards modelGynecologyRadiation therapyConfidence intervalMortalityChemotherapyBreast neoplasmRadiotherapyProgestogen ReceptorTamoxifen Aromatase Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being